WebGet the latest BioLine RX Ltd - ADR (BLRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. WebApr 6, 2024 · 285.52K. BioLineRx Ltd. (NASDAQ: BLRX) stock closed at 0.9975 per share at the end of the most recent trading day (a 3.64% change compared to the prior day closing price) with a volume of 397.24K shares and market capitalization of 61.38M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the …
BioLineRx - Wikipedia
WebMar 22, 2024 · About BioLineRx. BioLineRx Ltd. (NASDAQ/TASE: BLRX) is a pre-commercial-stage biopharmaceutical company focused on oncology. The Company's lead development program, motixafortide, a novel selective inhibitor of the CXCR4 chemokine receptor, may support diverse therapeutic approaches in oncology and other diseases. ... WebBiolinerx Ltd ADR stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Results are interpreted as buy, sell or hold signals, each with numeric ... css def fr
BioLineRx Ltd. (BLRX) At $0.64: It’s Worth Your Interest
WebDiscover historical prices for BLRX stock on Yahoo Finance. View daily, weekly or monthly format back to when BioLineRx Ltd. stock was issued. WebHow much is Biolinerx stock worth today? ( NASDAQ: BLRX) Biolinerx currently has 922,958,942 outstanding shares. With Biolinerx stock trading at $0.82 per share, the total value of Biolinerx stock (market capitalization) is $50.71M. Biolinerx stock was originally listed at a price of $75.45 in Jul 27, 2011. Webmidastouch017: BioLineRx Ltd. (BLRX) Primarily focused on oncology, BioLineRX in-licenses cutting-edge compounds, develops them through clinical stages and then p... Support: 888-992-3836 Home NewsWire Subscriptions css definition social